All
Dermatology Times, Digital Edition, September 2012
September 1st 2012Destination Unknown : Accountable care organizations & similar shared-savings models likely will impact dermatologists’ role in healthcare, but to what extent remains largely uncertain RNA & UV rays : Research sheds light on the inflammatory mechanism of sunburn Clinical Dermatology : Once-daily application of brimonidine tartrate gel safe, effective for facial erythema of rosacea Cosmetic Dermatology : Glycans and glycobiology emerge in development of anti-aging skincare products Cutaneous Oncology : AJCC’s melanoma staging system elicits debate among dermatologists Practice Management : Successful outsourcing can improve patient throughput, lower staffing costs
Melanoma risk in current melanoma patients demands careful, ongoing follow-up
September 1st 2012About 76,000 new cases of invasive melanoma occur in the United States each year, according to the American Cancer Society, and patients who have had one melanoma have a 5 to 10 percent risk of developing another primary tumor during their lifetime. As a result of this increased melanoma risk, careful follow-up of these patients is critical, a Harvard clinician advises.
Sandoz launches first-to-file calcipotriene cream, the first generic version of Dovonex
September 1st 2012Sandoz has announced the introduction of its first-to-file calcipotriene cream, the first generic version of LEO Pharma’s Dovonex 0.005 percent, which is indicated for the treatment of plaque psoriasis.
ELITech Molecular Diagnostics earns FDA clearance for real-time commercial MRSA/SA test
September 1st 2012ELITech Molecular Diagnostics has received FDA clearance for its MRSA/SA ELITe MGB test, a multiplex, qualitative real-time polymerase chain reaction assay for the detection of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus (MRSA) DNA purified from human nasal swab specimens.
Ellman International acquires Sandstone Medical Technologies
September 1st 2012Ellman International, a developer of radiofrequency technology for precision surgical and aesthetic procedures, has announced its acquisition of Sandstone Medical Technologies, developer of aesthetic laser and intense pulsed light technologies.
Dermatologic conditions can affect the mind, and vice versa
September 1st 2012Although dermatologic conditions most apparently affect the skin, dermatologists commonly encounter three types of psychodermatologic disorders where the mind and skin may interact, according to John Koo, M.D., professor and vice chairman, department of dermatology, University of California, San Francisco Medical Center.
Can the HEALTH Act of 2011 protect you from being sued?
September 1st 2012Dermatologist Joe Psoriasis is known throughout the country as an expert in the treatment of psoriasis. An inherent risk of treating such challenging patients is the higher risk of medical malpractice lawsuits. Dr. Psoriasis has now had five such lawsuits filed against him. He is contemplating discontinuing this portion of his practice. Will the HEALTH Act of 2011 provide him with more protection from such lawsuits?
Melanoma overlooked, has higher mortality in African-American patients
September 1st 2012While the incidence of melanoma is lower among African-Americans than it is among Caucasians, mortality due to melanoma is higher among the former. The reason, experts say, is because skin cancers in African-Americans appear on sites where they behave more aggressively, and there is a delay in diagnosis with this patient population.